Stay updated on ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Sign up to get notified when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision label updated from v3.4.2 to v3.4.3. No changes to study data or visible content.
    Difference
    0.0%
    Check dated 2026-03-05T22:16:59.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the funding-status notice and the old Revision: v3.4.1 entry were removed.
    Difference
    0.3%
    Check dated 2026-02-11T05:43:30.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A system-wide notice about potential data delays due to a lapse in government funding has been added, with links to cc.nih.gov and opm.gov. The page version has been updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:33:15.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Show glossary option added and minor wording tweaks to QC-related labels and revision references. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:55:07.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4, indicating a minor maintenance update.
    Difference
    0.0%
    Check dated 2026-01-14T02:37:58.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Locations section updated with new site listings for US (California, Colorado, Connecticut, Florida, Kansas, Michigan, Nevada, New York, North Carolina, Pennsylvania, Virginia, Wisconsin) and Canada (Alberta, Ontario). The revision label changed from v3.3.2 to v3.3.3 and the page's location headings were reorganized (removing the separate state/province subheadings).
    Difference
    1%
    Check dated 2025-12-23T14:33:12.000Z thumbnail image

Stay in the know with updates to ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.